Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Yes congrats to all. Tea and medals all round...zzzzzzzzzzzz
The closing auction might get you to 11p Dianne. That would cap off a tiring day for you posting like an olympic trader!!
Yes, well done, ria
Spot on now in the 9s.
Sadly I preferred it when I was on my own!
GL.
You could shorten that to DiaRia!!!
Get out quick as Dianne about to Dump. nice one Ria20.
New account ehh love
Thank god Ria's not here or she'd be jealous as hell of dianne's multiple posting. Or is Dianne Ria if you know what I mean? Mmmmm........
Slow down dianne or you'll not make it to the close of trading. Wouldn't want to be without your wonderful commentary tomorrow!! lol
…would be good to see this back above the original IPO price of 20p from 2020, especially given what they’ve achieved in developing Tutivia, Clarava and likely soon with Protega… the Thermo Fischer license deal validates the value and application of this in TF’s product portfolio and pivots Verici into being a license/IP play which should offer higher margins and revenues without the need to ramp costs across the board to achieve sales, etc. why re-invent the wheel when others have already done that do well!?
Hopefully Renalytix follows Verici’s lead here and both go on to recover far more than their original IPO valuations.
I continue to own both and have added more today to average down further, the king is dead, long live the king!!
Give it a rest, non-stop running commentary :) You should get a job commenting on football matches, lol.
25p first target and 100p Xmas gift 👍
Looks like a great stock and a tiny MC for the tech they have.
This reminds me of #POS Plexus stock when they received contract news. It moved nearly 650% from 2.50p to 20p.
Just slowly build your stake here and watch your investment flourish very soon.
Have been in here a long time.
This company has developed tests that will bring in millions.
Buy and hold.
GL.
With such a small mcap small number of shares in issue fully funded and that partnership …
Who the hell isn’t buying this?
It’s out of my area of knowledge but just on this alone it’s a screaming buy!
Nice big chuck of buys at £14,600 paid 11.42p
08:19:36 11.4229 127,813 14.60k
11p need to break then touch mid 18-20p very soon.
50% rise is nothing compared to 72p highs 👍
300% is good target, last placing at 35p and now JV deal with big boys 💰💰👌
Well, i was expecting a 50% rise on the news.it has my expectations, so im out. Good luck to all holders.
We also still have the following commercial use and median rate updates due before year end (taken from the RNS);
· Clarava™ is on track for initial US commercial use by the end of 2023 under prospective real-world evidence studies.
· Received preliminary gapfill median rate of $2,650 proposed for both Clarava™ and Tutivia™ by the Centers for Medicare & Medicaid Services ("CMS"). These rates are due to be finalised later this year and represent a substantial uplift from the Company's initial assumption for modelling purposes.
IN AUCTION
And jadams has arrived god save us.